In summary, the present study demonstrates that BPA uses a cell-specific gene expression signature in prostate cancer cells expressing a somatic mutation of AR, and that a major molecular consequence of BPA action is down-regulation of ERβ These studies provide insight into a potentially novel mechanism by which BPA can promote AR-T877A activity and androgen-independent cellular proliferation. Here, ESR2 is linked to prostate carcinoma.